Evidence map›Paper›PMID 33288768›Full record

ArticleNature communications2020

Heat Shock Factor 1-dependent extracellular matrix remodeling mediates the transition from chronic intestinal inflammation to colon cancer.

Oshrat Levi-Galibov, Hagar Lavon, Rina Wassermann-Dozorets, Meirav Pevsner-Fischer, Shimrit Mayer, Esther Wershof, Yaniv Stein, Lauren E Brown, Wenhan Zhang, Gil Friedman and 10 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed
4.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 102 citations in OpenAlex.

  1. Adaptation to heat stress by diversification of the vertebrate heat shock transcription factor family.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2026
    Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. 3-O-Acetyl-11-Keto-Oncology research · 2025
    Article
  18. Article
  19. Review
  20. A New Combination ofFoods (Basel, Switzerland) · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 6 institutions in 3 countries.

Oshrat Levi-GalibovDepartment of Biomolecular Sciences, The Weizmann Institute of Science, Rehovot, Israel.
Hagar LavonDepartment of Biomolecular Sciences, The Weizmann Institute of Science, Rehovot, Israel.
Rina Wassermann-DozoretsDepartment of Biomolecular Sciences, The Weizmann Institute of Science, Rehovot, Israel.
Meirav Pevsner-FischerDepartment of Biomolecular Sciences, The Weizmann Institute of Science, Rehovot, Israel.
Shimrit MayerDepartment of Biomolecular Sciences, The Weizmann Institute of Science, Rehovot, Israel.
Esther WershofThe Francis Crick Institute, London, UK.
Yaniv SteinDepartment of Biomolecular Sciences, The Weizmann Institute of Science, Rehovot, Israel.
Lauren E BrownDepartment of Chemistry and Center for Molecular Discovery (BU-CMD), Boston University, Boston, MA, USA.ORCID 0000-0001-9489-484X
Wenhan ZhangDepartment of Chemistry and Center for Molecular Discovery (BU-CMD), Boston University, Boston, MA, USA.
Gil FriedmanDepartment of Biomolecular Sciences, The Weizmann Institute of Science, Rehovot, Israel.
Reinat NevoDepartment of Biomolecular Sciences, The Weizmann Institute of Science, Rehovot, Israel.
Ofra GolaniDepartment of Life Sciences Core Facilities, The Weizmann Institute of Science, Rehovot, Israel.ORCID 0000-0002-9793-236X
Lior H KatzGastroenterology Institute, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel.
Rona YaegerGastrointestinal Oncology Service, Memorial Sloan Kettering Cancer Center, and Weil Cornell Medical College, New York, NY, USA.
Ido LaishGastroenterology Institute, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel.
John A PorcoDepartment of Chemistry and Center for Molecular Discovery (BU-CMD), Boston University, Boston, MA, USA.ORCID 0000-0002-2991-5680
Erik SahaiThe Francis Crick Institute, London, UK.ORCID 0000-0002-3932-5086
Dror S ShouvalSackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel.
David KelsenGastrointestinal Oncology Service, Memorial Sloan Kettering Cancer Center, and Weil Cornell Medical College, New York, NY, USA.ORCID 0000-0001-6139-438X
Ruth Scherz-ShouvalDepartment of Biomolecular Sciences, The Weizmann Institute of Science, Rehovot, Israel. ruth.shouval@weizmann.ac.il.ORCID 0000-0002-4570-121X
Weizmann Institute of Science · ILBoston University · USMemorial Sloan Kettering Cancer Center · USTel Aviv University · ILThe Francis Crick Institute · GBSheba Medical Center · IL

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI SELWYN M VICKERS · 1985 to 2026
$347.4M
Chemical Synthesis of Complex Natural Products for Translational ScienceR35GM118173 · NIGMS · BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) · PI JOHN A. PORCO · 2016 to 2026
$8.2M
BU-CMD Chemical Library Consortium: Fostering Collaborations between Chemists and Biologists for Translational DiscoveryU01TR002625 · NCATS · BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) · PI PORCO, JOHN A. · 2020 to 2023
$2.7M
Cancer Research UK FC010144Medical Research Council FC010144NCATS NIH HHS U01 TR002625NCI NIH HHS P30 CA008748NIGMS NIH HHS R35 GM118173Wellcome TrustWellcome Trust FC010144
6 · The paper itself

Abstract

In the colon, long-term exposure to chronic inflammation drives colitis-associated colon cancer (CAC) in patients with inflammatory bowel disease. While the causal and clinical links are well established, molecular understanding of how chronic inflammation leads to the development of colon cancer is lacking. Here we deconstruct the evolving microenvironment of CAC by measuring proteomic changes and extracellular matrix (ECM) organization over time in a mouse model of CAC. We detect early changes in ECM structure and composition, and report a crucial role for the transcriptional regulator heat shock factor 1 (HSF1) in orchestrating these events. Loss of HSF1 abrogates ECM assembly by colon fibroblasts in cell-culture, prevents inflammation-induced ECM remodeling in mice and inhibits progression to CAC. Establishing relevance to human disease, we find high activation of stromal HSF1 in CAC patients, and detect the HSF1-dependent proteomic ECM signature in human colorectal cancer. Thus, HSF1-dependent ECM remodeling plays a crucial role in mediating inflammation-driven colon cancer.

Indexed as

AnimalsCell Line, TumorCells, CulturedColitis-Associated NeoplasmsDisease Models, AnimalExtracellular MatrixHeat Shock Transcription FactorsHumansMass SpectrometryMice, 129 StrainMice, Inbred BALB CMice, KnockoutProteomeProteomicsHeat Shock Transcription FactorsProteome

Identifiers

PMID33288768
PMCPMC7721883
OpenAlexW3112415276

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.